Characteristics, onset, and evolution of neurological symptoms in patients with COVID-19.

Journal: Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology

Volume: 42

Issue: 1

Year of Publication: 2021

Affiliated Institutions:  Department of Neurology, LRSP, Clinical Investigation Center of Neurosciences and Mental Health, Universitary Hospital Razi-Mannouba, Tunis, Tunisia. Faculty of Medicine of Tunis, University of Tunis El Manar, Tunis, Tunisia. Department of Neurology, LRSP, Clinical Investigation Center of Neurosciences and Mental Health, Universitary Hospital Razi-Mannouba, Tunis, Tunisia. riadh.gouider@gnet.tn.

Abstract summary 

A wide range of neurological manifestations has been described in COVID-19.In this nationwide retrospective observational study, patients in Tunisia diagnosed with COVID-19 between the 2nd of March and the 16th of May 2020 were contacted by telephone. We collected demographic and clinical data and specified characteristics and evolution of main neurological symptoms.Of 1034 confirmed COVID-19 patients, 646 were included (mean age 42.17 years old) and 466 (72.1%) had neurological symptoms. Neurological symptoms were isolated 22.7% (n = 106). Headache was the most frequent neurological symptom (n = 279, 41.1%): mainly frontotemporal (n = 143, 51.1%) and mild or moderate (n = 165, 59.1%). When associated with fever (n = 143, 51.3%), headache was more likely to be severe and present at onset. Recovery was reported in 83.2%. Smell and taste impairment were found in 37.9% (n = 245) and 36.8% (n = 238) respectively. Among them, 65.3% (156/239) were anosmic and 63.2% (146/231) were ageusic. A complete improvement was found in 72.1% (174/240) of smell impairment and in 76.8% (179/233) of taste impairment. Myalgia (n = 241, 37.3%) and sleep disturbances (n = 241, 37.3%) were also frequent. Imported cases had more neurological symptoms (p = 0.001). In 14.5%, neurological symptoms preceded the respiratory signs (RS). RS were associated with more frequent (p = 0.006) and numerous (p < 0.001) neurological symptoms.Neurological symptoms in COVID-19 are frequent, can be isolated and present at onset. A total recovery is the most recorded outcome. RS are predictive of neurological symptoms. Studies in to virus and host genetics should be considered to understand the different phenotypes.

Authors & Co-authors:  Kacem Imen I Gharbi Alya A Harizi Chahida C Souissi Emira E Safer Mouna M Nasri Amina A Letaief Hajer H Akkari Manel M Hechaichi Aicha A Mrabet Saloua S Dhaouadi Sonia S Ben Djebara Mouna M Derouiche Sondes S Gargouri Amina A Chahed Mohamed M Ben Alaya Nissaf N Gouider Riadh R

Study Outcome 

Source Link: Visit source

Statistics
Citations :  Walls AC, Park Y-J, Tortorici MA, Wall A, McGuire AT, Veesler D (2020) Structure, function, and antigenicity of the SARS-CoV-2 spike glycoprotein. Cell. 10.1016/j.cell.2020.02.058
Authors :  17
Identifiers
Doi : 10.1007/s10072-020-04866-9
SSN : 1590-3478
Study Population
Male,Female
Mesh Terms
Adult
Other Terms
COVID-19;Neurological;SARS-CoV-2;Symptoms/manifestations;Tunisia
Study Design
Cross Sectional Study
Study Approach
Country of Study
Tunisia
Publication Country
Italy